Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Nicolas Barthelemy net worth and biography

Nicolas Barthelemy Biography and Net Worth

VP of 908 Devices

Nicolas Barthelemy is a life science industry veteran with 25 years of diverse expertise. He brings extensive experience in manufacturing, distributing and commercializing life science instruments, reagents and services, and knowledge of the research, clinical and bioprocessing markets as well as his public and private board experience. Mr. Barthelemy previously served as the President and Chief Executive Officer of Biotheranostics, Inc., a Molecular Diagnostics company. Prior to joining Biotheranostics, he held a variety of senior executive roles at Life Technologies until its acquisition by Thermo Fisher Scientific, including Chief Commercial Officer and President of the Cell Systems Division. Prior to joining Invitrogen (which later became Life Technologies), Mr. Barthelemy held a variety of operational and commercial roles with Biogen, Inc., including Vice President of Manufacturing. Before that, he held various technical positions at Merck & Co’s manufacturing division. Mr. Barthelemy currently serves on the board of directors of Repligen, Fluidigm and Genewiz and has previously served on the board of directors of Essen Bioscience. He holds an engineering degree from École Supérieure de Physique et Chimie Industrielles, France, as well as a master’s degree in chemical engineering from the University of California, Berkeley.

What is Nicolas Barthelemy's net worth?: The estimated net worth of Nicolas Barthelemy is at least $35,823.23 as of May 11th, 2022. Mr. Barthelemy owns 13,939 shares of 908 Devices stock worth more than $35,823 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Barthelemy may own. Learn More about Nicolas Barthelemy's net worth.
How do I contact Nicolas Barthelemy?: The corporate mailing address for Mr. Barthelemy and other 908 Devices executives is , , . 908 Devices can also be reached via phone at 857-254-1500 and via email at [email protected]. Learn More on Nicolas Barthelemy's contact information.
Has Nicolas Barthelemy been buying or selling shares of 908 Devices?: Nicolas Barthelemy has not been actively trading shares of 908 Devices within the last three months. Most recently, Nicolas Barthelemy sold 4,000 shares of the business's stock in a transaction on Thursday, June 24th. The shares were sold at an average price of $40.00, for a transaction totalling $160,000.00. Following the completion of the sale, the vice president now directly owns 3,000 shares of the company's stock, valued at $120,000. Learn More on Nicolas Barthelemy's trading history.
Who are 908 Devices' active insiders?: 908 Devices' insider roster includes Nicolas Barthelemy (VP), Trent Basarsky (VP), Christopher Brown (CTO), Joseph Griffith, IV (CFO), John Kenneweg (VP), and Kevin Knopp (CEO). Learn More on 908 Devices' active insiders.
Are insiders buying or selling shares of 908 Devices?: In the last year, 908 Devices insiders bought shares 3 times. They purchased a total of 30,000 shares worth more than $178,500.00. In the last year, insiders at the sold shares 6 times. They sold a total of 40,346 shares worth more than $324,982.08. The most recent insider tranaction occured on May, 13th when CEO Kevin J Knopp bought 10,000 shares worth more than $64,200.00. Insiders at 908 Devices own 27.7% of the company. Learn More about insider trades at 908 Devices.
Information on this page was last updated on 5/13/2024.

Nicolas Barthelemy Insider Trading History at 908 Devices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/24/2021	Sell	4,000	$40.00	$160,000.00	3,000

Nicolas Barthelemy Buying and Selling Activity at 908 Devices

908 Devices Company Overview

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $2.74

$2.52

$2.82

50 Day Range

MA: $3.36

$2.34

$3.91

2 Week Range

Now: $2.74

$2.19

$12.51

Volume

543,857 shs

Average Volume

210,283 shs

Market Capitalization

$95.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad